Equitable Trust’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-85,430
Closed -$613K – 483
2024
Q3
$613K Sell
85,430
-3,506
-4% -$24.9K 0.04% 272
2024
Q2
$652K Hold
88,936
– – 0.04% 250
2024
Q1
$890K Buy
88,936
+6,250
+8% +$54.7K 0.06% 218
2023
Q4
$580K Sell
82,686
-14,793
-15% -$98.4K 0.04% 255
2023
Q3
$774K Buy
97,479
+24,487
+34% +$154K 0.06% 194
2023
Q2
$404K Sell
72,992
-14,025
-16% -$76.9K 0.03% 291
2023
Q1
$495K Sell
87,017
-138,400
-61% -$916K 0.04% 252
2022
Q4
$1.58M Buy
225,417
+178,178
+377% +$1.83M 0.12% 145
2022
Q3
$421K Sell
47,239
-4,046
-8% -$46.7K 0.04% 275
2022
Q2
$531K Sell
51,285
-1,760
-3% -$26.1K 0.04% 247
2022
Q1
$1.11M Buy
53,045
+15,336
+41% +$335K 0.07% 165
2021
Q4
$965K Buy
+37,709
New +$1.04M 0.06% 183

Other funds holding MSOS

Equitable Trust's MSOS Position: Q4 2024 in Review

Equitable Trust sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2024, closing a stake of 85,430 shares — an estimated $613K sold.

Equitable Trust first reported a position in MSOS in Q4 2021 and held it in 12 quarters. The position peaked at $1.58M in Q4 2022. 178 funds tracked by Wall St. Rank hold MSOS as of Q4 2024.

  • Equitable Trust reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2024 after selling out during the quarter.
  • Equitable Trust sold 85,430 AdvisorShares Pure US Cannabis ETF shares in Q4 2024, an estimated $613K.
  • Equitable Trust first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 12 quarters.
  • Equitable Trust's AdvisorShares Pure US Cannabis ETF position peaked at $1.58M in Q4 2022.
  • 178 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2024.

Based on Equitable Trust's 13F filing for Q4 2024, filed 28 Jan 2025.